BRADY CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BRADY CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jul 31, 2021 | $306.13M | Sep 2, 2021 |
| FY2021 | Apr 30, 2021 | $295.50M | Sep 2, 2021 |
| FY2021 | Jan 31, 2021 | $265.84M | Sep 2, 2021 |
| FY2021 | Oct 31, 2020 | $277.23M | Sep 2, 2021 |
| FY2021 | Jul 31, 2020 | $251.74M | Sep 2, 2021 |
| FY2021 | Apr 30, 2020 | $265.94M | Sep 2, 2021 |
| FY2021 | Jan 31, 2020 | $276.67M | Sep 2, 2021 |
| FY2021 | Oct 31, 2019 | $286.95M | Sep 2, 2021 |
| FY2020 | Jul 31, 2019 | $295.28M | Sep 16, 2020 |
| FY2020 | Apr 30, 2019 | $289.75M | Sep 16, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $1.51B | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $1.34B | Sep 4, 2025 |
| FY2025 | Jul 31, 2023 | $1.33B | Sep 4, 2025 |
| FY2024 | Jul 31, 2022 | $1.30B | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $1.14B | Sep 5, 2023 |
| FY2022 | Jul 31, 2020 | $1.08B | Sep 1, 2022 |
| FY2021 | Jul 31, 2019 | $1.16B | Sep 2, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $760.82M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $687.88M | Sep 4, 2025 |
| FY2025 | Jul 31, 2023 | $657.28M | Sep 4, 2025 |
| FY2024 | Jul 31, 2022 | $631.55M | Sep 6, 2024 |
| FY2021 | Jul 31, 2021 | $147.65M | Sep 2, 2021 |
| FY2021 | Apr 30, 2021 | $148.85M | Sep 2, 2021 |
| FY2021 | Jan 31, 2021 | $129.52M | Sep 2, 2021 |
| FY2021 | Oct 31, 2020 | $135.43M | Sep 2, 2021 |
| FY2021 | Jul 31, 2020 | $118.51M | Sep 2, 2021 |
| FY2021 | Apr 30, 2020 | $129.53M | Sep 2, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $189.26M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $197.22M | Sep 4, 2025 |
| FY2025 | Jul 31, 2023 | $174.86M | Sep 4, 2025 |
| FY2025 | Jul 31, 2022 | $149.98M | Sep 4, 2025 |
| FY2025 | Jul 31, 2021 | $129.66M | Sep 4, 2025 |
| FY2022 | Jul 31, 2020 | $112.37M | Sep 1, 2022 |
| FY2021 | Jul 31, 2019 | $131.26M | Sep 2, 2021 |
| FY2020 | Jul 31, 2018 | $91.06M | Sep 16, 2020 |
| FY2019 | Jul 31, 2017 | $95.65M | Sep 6, 2019 |
| FY2018 | Jul 31, 2016 | $80.11M | Sep 13, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $236.64M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $243.41M | Sep 4, 2025 |
| FY2025 | Jul 31, 2023 | $225.21M | Sep 4, 2025 |
| FY2024 | Jul 31, 2022 | $193.01M | Sep 6, 2024 |
| FY2021 | Jul 31, 2021 | $40.80M | Sep 2, 2021 |
| FY2021 | Apr 30, 2021 | $46.73M | Sep 2, 2021 |
| FY2021 | Jan 31, 2021 | $37.41M | Sep 2, 2021 |
| FY2021 | Oct 31, 2020 | $42.19M | Sep 2, 2021 |
| FY2021 | Jul 31, 2020 | $33.22M | Sep 2, 2021 |
| FY2021 | Apr 30, 2020 | $22.67M | Sep 2, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $79.89M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $67.75M | Sep 4, 2025 |
| FY2025 | Jul 31, 2023 | $61.37M | Sep 4, 2025 |
| FY2024 | Jul 31, 2022 | $58.55M | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $44.55M | Sep 5, 2023 |
| FY2022 | Jul 31, 2020 | $40.66M | Sep 1, 2022 |
| FY2021 | Jul 31, 2019 | $45.17M | Sep 2, 2021 |
| FY2020 | Jul 31, 2018 | $45.25M | Sep 16, 2020 |
| FY2019 | Jul 31, 2017 | $39.62M | Sep 6, 2019 |
| FY2018 | Jul 31, 2016 | $35.80M | Sep 13, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $444.30M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $376.72M | Sep 4, 2025 |
| FY2025 | Jul 31, 2023 | $370.70M | Sep 4, 2025 |
| FY2024 | Jul 31, 2022 | $379.99M | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $349.77M | Sep 5, 2023 |
| FY2022 | Jul 31, 2020 | $336.06M | Sep 1, 2022 |
| FY2021 | Jul 31, 2019 | $371.08M | Sep 2, 2021 |
| FY2020 | Jul 31, 2018 | $390.34M | Sep 16, 2020 |
| FY2019 | Jul 31, 2017 | $387.65M | Sep 6, 2019 |
| FY2018 | Jul 31, 2016 | $405.10M | Sep 13, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $181.20M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $255.07M | Sep 4, 2025 |
| FY2025 | Jul 31, 2023 | $209.15M | Sep 4, 2025 |
| FY2024 | Jul 31, 2022 | $118.45M | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $205.67M | Sep 5, 2023 |
| FY2022 | Jul 31, 2020 | $140.98M | Sep 1, 2022 |
| FY2021 | Jul 31, 2019 | $162.21M | Sep 2, 2021 |
| FY2020 | Jul 31, 2018 | $143.04M | Sep 16, 2020 |
| FY2019 | Jul 31, 2017 | $144.03M | Sep 6, 2019 |
| FY2018 | Jul 31, 2016 | $138.98M | Sep 13, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $27.58M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $79.89M | Sep 4, 2025 |
| FY2025 | Jul 31, 2023 | $19.23M | Sep 4, 2025 |
| FY2024 | Jul 31, 2022 | $43.14M | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $27.19M | Sep 5, 2023 |
| FY2022 | Jul 31, 2020 | $27.28M | Sep 1, 2022 |
| FY2021 | Jul 31, 2019 | $32.83M | Sep 2, 2021 |
| FY2020 | Jul 31, 2018 | $21.78M | Sep 16, 2020 |
| FY2019 | Jul 31, 2017 | $15.17M | Sep 6, 2019 |
| FY2018 | Jul 31, 2016 | $17.14M | Sep 13, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $1.73B | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $1.52B | Sep 4, 2025 |
| FY2025 | Jul 31, 2023 | $1.39B | Sep 4, 2025 |
| FY2024 | Jul 31, 2022 | $1.37B | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $1.38B | Sep 5, 2023 |
| FY2022 | Jul 31, 2020 | $1.14B | Sep 1, 2022 |
| FY2021 | Jul 31, 2019 | $1.16B | Sep 2, 2021 |
| FY2020 | Jul 31, 2018 | $1.06B | Sep 16, 2020 |
| FY2019 | Jul 31, 2017 | $1.05B | Sep 6, 2019 |
| FY2018 | Jul 31, 2016 | $1.04B | Sep 13, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $542.04M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $448.91M | Sep 4, 2025 |
| FY2024 | Jul 31, 2023 | $398.34M | Sep 6, 2024 |
| FY2023 | Jul 31, 2022 | $456.03M | Sep 5, 2023 |
| FY2022 | Jul 31, 2021 | $414.73M | Sep 1, 2022 |
| FY2021 | Jul 31, 2020 | $279.39M | Sep 2, 2021 |
| FY2020 | Jul 31, 2019 | $306.53M | Sep 16, 2020 |
| FY2019 | Jul 31, 2018 | $304.82M | Sep 6, 2019 |
| FY2018 | Jul 31, 2017 | $350.08M | Sep 13, 2018 |
| FY2017 | Jul 31, 2016 | $440.37M | Sep 13, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $1.19B | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $1.07B | Sep 4, 2025 |
| FY2024 | Jul 31, 2023 | $990.92M | Sep 6, 2024 |
| FY2023 | Jul 31, 2022 | $911.30M | Sep 5, 2023 |
| FY2022 | Jul 31, 2021 | $963.03M | Sep 1, 2022 |
| FY2022 | Jul 31, 2020 | $752.11M | Sep 1, 2022 |
| FY2022 | Jul 31, 2019 | $700.14M | Sep 1, 2022 |
| FY2021 | Jul 31, 2018 | $700.14M | Sep 2, 2021 |
| FY2020 | Jul 31, 2017 | $700.14M | Sep 16, 2020 |
| FY2019 | Jul 31, 2016 | $603.60M | Sep 6, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $676.95M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $589.61M | Sep 4, 2025 |
| FY2025 | Jul 31, 2023 | $592.65M | Sep 4, 2025 |
| FY2024 | Jul 31, 2022 | $586.83M | Sep 6, 2024 |
| FY2023 | Jul 31, 2021 | $614.14M | Sep 5, 2023 |
| FY2022 | Jul 31, 2020 | $416.03M | Sep 1, 2022 |
| FY2021 | Jul 31, 2019 | $410.99M | Sep 2, 2021 |
| FY2020 | Jul 31, 2018 | $419.82M | Sep 16, 2020 |
| FY2019 | Jul 31, 2017 | $437.70M | Sep 6, 2019 |
| FY2018 | Jul 31, 2016 | $429.87M | Sep 13, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $1.32B | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $1.17B | Sep 4, 2025 |
| FY2024 | Jul 31, 2023 | $1.02B | Sep 6, 2024 |
| FY2023 | Jul 31, 2022 | $892.42M | Sep 5, 2023 |
| FY2022 | Jul 31, 2021 | $788.37M | Sep 1, 2022 |
| FY2021 | Jul 31, 2020 | $704.46M | Sep 2, 2021 |
| FY2020 | Jul 31, 2019 | $637.84M | Sep 16, 2020 |
| FY2019 | Jul 31, 2018 | $553.45M | Sep 6, 2019 |
| FY2018 | Jul 31, 2017 | $507.14M | Sep 13, 2018 |
| FY2017 | Jul 31, 2016 | $453.37M | Sep 13, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $174.35M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $250.12M | Sep 4, 2025 |
| FY2024 | Jul 31, 2023 | $151.53M | Sep 6, 2024 |
| FY2023 | Jul 31, 2022 | $114.07M | Sep 5, 2023 |
| FY2022 | Jul 31, 2021 | $147.34M | Sep 1, 2022 |
| FY2021 | Jul 31, 2020 | $217.64M | Sep 2, 2021 |
| FY2021 | Jul 31, 2019 | $279.07M | Sep 2, 2021 |
| FY2021 | Jul 31, 2018 | $181.43M | Sep 2, 2021 |
| FY2020 | Jul 31, 2017 | $133.94M | Sep 16, 2020 |
| FY2019 | Jul 31, 2016 | $141.23M | Sep 6, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $99.77M | Sep 4, 2025 |
| FY2025 | Jul 31, 2024 | $90.94M | Sep 4, 2025 |
| FY2020 | Jul 31, 2019 | $50.17M | Sep 16, 2020 |
| FY2019 | Jul 31, 2018 | $52.62M | Sep 6, 2019 |
| FY2014 | Jul 31, 2014 | $201.81M | Sep 29, 2014 |
| FY2014 | Jul 31, 2013 | $262.41M | Sep 29, 2014 |
| FY2013 | Jul 31, 2012 | $316.21M | Sep 30, 2013 |
| FY2012 | Jul 31, 2011 | $393.18M | Sep 27, 2012 |
| FY2011 | Jul 31, 2010 | $444.20M | Sep 27, 2011 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Jul 31, 2020 | $45.76M | Sep 16, 2020 |
| FY2020 | Jul 31, 2019 | $44.73M | Sep 16, 2020 |
| FY2020 | Jul 31, 2018 | $42.87M | Sep 16, 2020 |
| FY2019 | Jul 31, 2017 | $41.88M | Sep 6, 2019 |
| FY2018 | Jul 31, 2016 | $40.81M | Sep 13, 2018 |
| FY2017 | Jul 31, 2015 | $40.98M | Sep 13, 2017 |
| FY2016 | Jul 31, 2014 | $40.49M | Sep 15, 2016 |
| FY2015 | Jul 31, 2013 | $39.24M | Sep 21, 2015 |
| FY2014 | Jul 31, 2012 | $38.90M | Sep 29, 2014 |
| FY2013 | Jul 31, 2011 | $38.06M | Sep 30, 2013 |